Higher risk of bleeding in atrial fibrillation patients taking blood thinner dabigatran

Patients with atrial fibrillation who take the blood thinner dabigatran are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new study. The findings, based on Medicare claims data, indicate greater caution is needed when prescribing dabigatran to certain high-risk patients. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *